Full Press Release Details
Webcast Analyst Day Meeting
DUBLIN--(BUSINESS WIRE)--May 9, 2014--ICON plc, (NASDAQ:ICLR), a
global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries, today
announced that it will provide a live webcast of its Analyst Day meeting
which will take place on Wednesday, 14th May, 2014 in North
Wales, Philadelphia, starting at 9:30 a.m. EST. The event will include
presentations from members of ICON's executive team. It is expected that
the presentations, followed by a question and answer session, will
conclude by approximately 12:15 p.m. EST.
This webcast and accompanying slide presentation will be accessible live
from our website at http://investor.iconplc.com. A recording will
also be available on the website for 90 days following the webcast. In
addition, a calendar of company events, including upcoming conference
presentations, is available on our website, under "Investors". This
calendar will be updated regularly.
This press release contains forward-looking statements. These statements
are based on management's current expectations and information currently
available, including current economic and industry conditions. These
statements are not guarantees of future performance or actual results,
and actual results, developments and business decisions may differ from
those stated in this press release. The forward-looking statements are
subject to future events, risks, uncertainties and other factors that
could cause actual results to differ materially from those projected in
the statements, including, but not limited to, the ability to enter into
new contracts, maintain client relationships, manage the opening of new
offices and offering of new services, the integration of new business
mergers and acquisitions, as well as economic and global market
conditions and other risks and uncertainties detailed from time to time
in SEC reports filed by ICON, all of which are difficult to predict and
some of which are beyond our control. For these reasons, you should not
place undue reliance on these forward-looking statements when making
investment decisions. The word "expected" and variations of such words
and similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they are
made and we do not undertake any obligation to update publicly any
forward-looking statement, either as a result of new information, future
events or otherwise. More information about the risks and uncertainties
relating to these forward-looking statements may be found in SEC reports
filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are
available on the SEC's website at http://www.sec.gov.
ICON plc is a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries. The company
specialises in the strategic development, management and analysis of
programs that support clinical development - from compound selection to
Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON
currently, operates from 76 locations in 37 countries and has
approximately 10,300 employees. Further information is available at www.iconplc.com.
Brennan, + 353 -1-291-2000
Chief Financial Officer
Holmes, + 353 -1-291-2000
EVP Investor Relations and Corporate